What Is the Optimal Management of Dysphagia in Metastatic Esophageal Cancer?
Oncological Surgery Unit, Veneto Institute of Oncology (iov-irccs), Padova, Italy
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2012, 19(6), 501; https://doi.org/10.3747/co.19.1153
Submission received: 6 September 2012
/
Revised: 4 October 2012
/
Accepted: 2 November 2012
/
Published: 1 December 2012
Excerpt
Note: In lieu of an abstract, this is an excerpt from the first page.
Hanna et al. investigated the improvement in dysphagia score (ds) in inoperable esophageal cancer treated with endoluminal stenting or radiation therapy. [...]
Share and Cite
MDPI and ACS Style
Cavallin, F.; Scarpa, M.; Cagol, M.; Alfieri, R.; Castoro, C. What Is the Optimal Management of Dysphagia in Metastatic Esophageal Cancer? Curr. Oncol. 2012, 19, 501. https://doi.org/10.3747/co.19.1153
AMA Style
Cavallin F, Scarpa M, Cagol M, Alfieri R, Castoro C. What Is the Optimal Management of Dysphagia in Metastatic Esophageal Cancer? Current Oncology. 2012; 19(6):501. https://doi.org/10.3747/co.19.1153
Chicago/Turabian StyleCavallin, Francesco, Marco Scarpa, Matteo Cagol, Rita Alfieri, and Carlo Castoro. 2012. "What Is the Optimal Management of Dysphagia in Metastatic Esophageal Cancer?" Current Oncology 19, no. 6: 501. https://doi.org/10.3747/co.19.1153
